Immunoglobulin G3 blocking antibodies to the fungal pathogen Cryptococcus neoformans.
about
Vaccine-mediated immune responses to experimental pulmonary Cryptococcus gattii infection in micePassive administration of monoclonal antibodies to anthrolysin O prolong survival in mice lethally infected with Bacillus anthracisUsing monoclonal antibodies to prevent mucosal transmission of epidemic infectious diseases.Peptide mimic of phosphorylcholine, a dominant epitope found on Streptococcus pneumoniaeCharacterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies.Isotype switching increases efficacy of antibody protection against Cryptococcus neoformans infection in miceSerologic response to cell wall mannoproteins and proteins of Candida albicansBinding to and opsonophagocytic activity of O-antigen-specific monoclonal antibodies against encapsulated and nonencapsulated Klebsiella pneumoniae serotype O1 strains.Both Th1 and Th2 cytokines affect the ability of monoclonal antibodies to protect mice against Cryptococcus neoformans.Immunoglobulin G monoclonal antibodies to Cryptococcus neoformans protect mice deficient in complement component C3Self-adjuvanting glycopeptide conjugate vaccine against disseminated candidiasis.Conserved natural IgM antibodies mediate innate and adaptive immunity against the opportunistic fungus Pneumocystis murina.Role of B cells and antibodies in acquired immunity against Mycobacterium tuberculosis.Human immunoglobulin G2 (IgG2) and IgG4, but not IgG1 or IgG3, protect mice against Cryptococcus neoformans infection.New concepts in antibody-mediated immunity.T cells cooperate with passive antibody to modify Cryptococcus neoformans infection in mice.Vaccine and immunotherapeutic approaches for the prevention of cryptococcosis: lessons learned from animal models.Characterization of gp70 and anti-gp70 monoclonal antibodies in Paracoccidioides brasiliensis pathogenesis.Epitope location in the Cryptococcus neoformans capsule is a determinant of antibody efficacy.Antibody-mediated modulation of Cryptococcus neoformans infection is dependent on distinct Fc receptor functions and IgG subclassesProtective and destructive immunity in the periodontium: Part 1--innate and humoral immunity and the periodontium.Disease-enhancing antibodies improve the efficacy of bacterial toxin-neutralizing antibodiesAntifungal immunotherapy and immunomodulation: a double-hitter approach to deal with invasive fungal infections.A proteomic-based approach for the identification of immunodominant Cryptococcus neoformans proteins.Immunoglobulins in defense, pathogenesis, and therapy of fungal diseases.Cryptococcus antigens and immune responses: implications for a vaccine.The protective role of immunoglobulins in fungal infections and inflammation.Serum therapy for tuberculosis revisited: reappraisal of the role of antibody-mediated immunity against Mycobacterium tuberculosis.
P2860
Q28541882-B53BF03E-DCF1-494C-9B49-0C0980CA3C44Q33371386-F8EE9551-000F-4057-9B88-AB14A72A999AQ33542433-284FB929-87A9-4D66-8B62-D417D364EB88Q33592253-01ECE95A-FE96-448A-A55B-66323480D027Q33693515-9F432D8D-CC79-4DC5-9E2E-102BDD66ED14Q33751509-BDDA663F-AE37-4CF0-9E1A-BA451D3DEB57Q33992594-C94EDB1C-0897-4F88-AFA0-2FAE594CBC9BQ34004100-C84C77EB-4BBF-4FF4-B18D-CDAF6815F514Q34009446-302C9A66-6034-4286-A780-68DD30F1C65CQ34121516-FCB799A1-9D09-4224-AC2E-1AE58169127CQ34259665-81991493-ADA1-4F18-8660-BF3FC5465401Q34420814-46B9BCAC-7EFA-48C0-950C-C92F19639AFDQ35164284-1C71EADF-3E58-43EF-8C5F-787D48B7BED0Q35689463-2D5D4179-DAA2-4065-84C9-BA3E265599A1Q35926507-2B04D63A-A0A6-4848-8F41-1519EBEAEC53Q36047782-B6ACC3CB-3090-4E43-AB08-40A6DC8DA55CQ36192774-61DCD8E0-6010-4011-9A5B-FB1D00E12BF6Q36375275-4DD04EE8-8495-40BA-A4D0-7C7CBF4BE9D3Q36376827-6C9CCDAA-61D5-4D93-AD72-80518BE40663Q36400281-D965C81F-4B6D-4A42-9141-D59A21FAD290Q36404749-161F62F7-1552-4982-8F64-DCAD00641D4EQ36786293-B29F0B9E-C19D-496D-87A8-2AA8161799D4Q37132306-E6C10559-E502-411D-BF2E-9DB4D8FF52A9Q37367575-46C83526-A3FA-4006-B22A-51A29F254AE8Q38011299-448BF9DE-51C6-469D-BD64-EA8B2E7A8440Q38155197-5C7EC4FC-10FF-4CC4-9100-0DE1B11E03CAQ38268922-BD25E9AD-A949-4253-9431-331E8CA93C76Q39468908-66EBC858-BEEF-466B-8C2C-04F656EBE61A
P2860
Immunoglobulin G3 blocking antibodies to the fungal pathogen Cryptococcus neoformans.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Immunoglobulin G3 blocking antibodies to the fungal pathogen Cryptococcus neoformans.
@ast
Immunoglobulin G3 blocking antibodies to the fungal pathogen Cryptococcus neoformans.
@en
type
label
Immunoglobulin G3 blocking antibodies to the fungal pathogen Cryptococcus neoformans.
@ast
Immunoglobulin G3 blocking antibodies to the fungal pathogen Cryptococcus neoformans.
@en
prefLabel
Immunoglobulin G3 blocking antibodies to the fungal pathogen Cryptococcus neoformans.
@ast
Immunoglobulin G3 blocking antibodies to the fungal pathogen Cryptococcus neoformans.
@en
P2093
P2860
P356
P1476
Immunoglobulin G3 blocking antibodies to the fungal pathogen Cryptococcus neoformans.
@en
P2093
A Casadevall
G Nussbaum
M D Scharff
P2860
P304
P356
10.1084/JEM.183.4.1905
P407
P577
1996-04-01T00:00:00Z